Published in Thromb Res on July 15, 1993
Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37
[Cholesterol--a marker for multiple risk factors? A comparison between coronary disease and coronary health]. Dtsch Med Wochenschr (1992) 1.39
DNA bending by the silencer protein NeP1 is modulated by TR and RXR. Nucleic Acids Res (1996) 1.20
Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield. Respir Med (2012) 1.19
Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J (2016) 1.01
Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry (2002) 1.00
Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med (2008) 0.98
Pharmacological survey of recombinant hirudin. Pharmazie (1988) 0.95
Ultrasonic force microscopy on strained antimony nanoparticles. Ultramicroscopy (2007) 0.95
Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell (1998) 0.94
Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am J Ind Med (2007) 0.89
Urea utilization in the phototrophic bacterium Rhodobacter capsulatus is regulated by the transcriptional activator NtrC. J Bacteriol (2001) 0.88
Silicon based tandem cells: novel photocathodes for hydrogen production. Phys Chem Chem Phys (2014) 0.87
Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol (2012) 0.84
Effects of growth hormone administration in pediatric renal allograft recipients. Pediatr Nephrol (1992) 0.82
Incisional hernia after periacetabular osteotomy. Clin Orthop Relat Res (2004) 0.82
An improved time-of-flight method for cluster deposition and ion-scattering experiments. Rev Sci Instrum (2008) 0.81
Localization of injected apolipophorin III in vivo - new insights into the immune activation process directed by this protein. J Insect Physiol (2001) 0.80
Ultrasonography in the diagnosis of transient synovitis of the hip and Legg-Calvé-Perthes disease. J Pediatr Orthop B (1999) 0.80
[The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide]. Pharmazie (1987) 0.79
[Influence of folic acid on rat hepatocytes]. Beitr Pathol (1972) 0.79
[Indications and outcome of ventilated patients treated in a neurological intensive care unit]. Nervenarzt (2012) 0.79
Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors. Thromb Res (1986) 0.78
Oral cyclosporine pharmacokinetics in pediatric renal and liver transplant recipients. Transplant Proc (1994) 0.78
[Clinical relevance and indications for cardiac magnetic resonance imaging 2013: an interdisciplinary expert statement]. Rofo (2013) 0.78
Studies on antithrombotic effects of recombinant hirudin. Thromb Res (1989) 0.78
Anticoagulant action of synthetic tight binding inhibitors of thrombin in vitro and in vivo. Thromb Res (1985) 0.77
Neutron small-angle scattering from aqueous solutions of oxy- and deoxyhaemoglobin. J Mol Biol (1969) 0.77
Reduction of a benzamidoxime derivative to the corresponding benzamidine in vivo and in vitro. Pharmazie (1988) 0.77
Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats. Thromb Res (2001) 0.77
[Ischemic complications in aortic dissection--percutaneous treatment with balloon fenestration and stent implantation]. Rofo (1999) 0.76
Afterload reduction in severe aortic regurgitation. J Magn Reson Imaging (2001) 0.76
[Ultrasonic echocardiograms in patients with artificial mitral valves (Starr-Edwards prothesis)]. Z Kreislaufforsch (1967) 0.76
Phospholipase A2 is involved in chemotaxis of human leukocytes. Adv Exp Med Biol (1999) 0.76
Pharmacological characterization of a new highly effective synthetic thrombin inhibitor. Biomed Biochim Acta (1985) 0.76
Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit. Br J Pharmacol (2011) 0.75
[Factors associated with HPV immunization for 13-14-year-old girls in the Geneva district, Switzerland]. Rev Epidemiol Sante Publique (2013) 0.75
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation (1990) 0.75
[Pharmacological effect of pentacyanonitrosylferrate and similar complex compounds]. Acta Biol Med Ger (1978) 0.75
[Costs of usual and recommended nutrition of infants and pre-schoolers]. Kinderkrankenschwester (1997) 0.75
[Prenatal AB0(H) blood group determination of amniotic fluid cells by mixed cell agglutination]. Zentralbl Gynakol (1982) 0.75
[Vitamin D hypercalcemic heart and vascular disease]. Monatsschr Kinderheilkd (1966) 0.75
Pharmacological characterization of a new structural variant of 4-amidinophenylalanine amide-type synthetic thrombin inhibitor. Pharmazie (1989) 0.75
[Mould and dampness in houses: health, environmental and social aspects - results of a study by the Bremen local public health office]. Gesundheitswesen (2008) 0.75
[Peritoneoscopy with 2 optical devices: reduced risk - better diagnostic results (author's transl)]. Leber Magen Darm (1976) 0.75
Three cases of stroke in patients with atypical presentation of type a aortic dissection--potential of neurosonography in the early diagnosis of atypical stroke. Ultraschall Med (2011) 0.75
[Liberation of plasminogen activators]. Folia Haematol Int Mag Klin Morphol Blutforsch (1976) 0.75
[Vitamin D-hypercalcemia cardiovascular disease]. Dtsch Med Wochenschr (1966) 0.75
[Metabolism of insulin and glucagon. Heterogeneity and characterization of insulin and glucagon degrading enzyme systems in cell fractions of the rat liver]. Acta Biol Med Ger (1972) 0.75
["Long live the new survey". Comments on the current/future Environmental Survey]. Gesundheitswesen (1999) 0.75
Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro. Blood Coagul Fibrinolysis (1993) 0.75
Cyclosporine pharmacokinetics in pediatric liver transplant recipients: utility of the monoclonal radioimmunoassay single point blood concentration. Transplant Proc (1994) 0.75
Retracted Spinal leptomeningeal metastases from prostate cancer. Acta Neurochir (Wien) (2005) 0.75
Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants. Pediatr Nephrol (1993) 0.75
[ABO blood group advanced age]. Z Arztl Fortbild (Jena) (1982) 0.75
Problems of an optimum digitalis therapy. Int J Clin Pharmacol Ther Toxicol (1980) 0.75
Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor. Thromb Haemost (1986) 0.75
Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin. Thromb Haemost (1980) 0.75
Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients. Pharmacotherapy (1995) 0.75
Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors. Thromb Haemost (1990) 0.75
Spinal leptomeningeal metastases from prostate cancer. J Neurooncol (2006) 0.75
Haemostyptic effects of batroxobin with regard to hirudin treatment. Thromb Res (1992) 0.75
Human centromere mapping using teratoma data. Cytogenet Cell Genet (1976) 0.75
Use of Neoral in pediatric renal transplantation. Transplant Proc (1996) 0.75
Biliary excretion of synthetic benzamidine-type thrombin inhibitors in rabbits and rats. Biomed Biochim Acta (1987) 0.75
[3H]dihydroergocryptine binding to alpha-adrenoceptors in human femoral veins and arteries. Biomed Biochim Acta (1984) 0.75
In vitro and in vivo comparison of arginine- and benzamidine-derived highly potent synthetic thrombin inhibitors. Pharmazie (1991) 0.75